South Korea is accelerating bio-innovation through the use of ai and synthetic biology, with the goal of creating the world's largest biofoundry. The country is partnering with various entities, including google deepmind, to bring advanced ai models to its scientific community and expand ai research. The effort is part of a broader initiative to drive scientific innovation and reshape the global healthcare landscape through the use of ai, gene editing, and advanced biologics.